A detailed history of Richardson Financial Services Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Richardson Financial Services Inc. holds 937 shares of VRTX stock, worth $451,530. This represents 0.28% of its overall portfolio holdings.

Number of Shares
937
Previous 597 56.95%
Holding current value
$451,530
Previous $243 Million 61.24%
% of portfolio
0.28%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $138,614 - $151,667
340 Added 56.95%
937 $392 Million
Q4 2023

Mar 04, 2024

BUY
$343.0 - $410.68 $204,771 - $245,175
597 New
597 $243 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Richardson Financial Services Inc. Portfolio

Follow Richardson Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richardson Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richardson Financial Services Inc. with notifications on news.